Headache

Seminars in Neurology

Volumn 31, Issue 1, 2011, Pages 5-17

  Mathew, Paul G ^a,b   Garza, Ivan ^c  

^a Brigham and Women's/Faulkner Hospitals   (United States)

^b CAMBRIDGE HEALTH ALLIANCE   (United States)

^c MAYO CLINIC   (United States)

Author keywords

cluster headache; migraine; Primary headache; tension type headache; trigeminal autonomic cephalgias

Indexed keywords

ACETYLSALICYLIC ACID; ALMOTRIPTAN; AMITRIPTYLINE; ATENOLOL; BOTULINUM TOXIN A; DIHYDROERGOTAMINE; ELETRIPTAN; FROVATRIPTAN; GABAPENTIN; LITHIUM; MIRTAZAPINE; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; PARACETAMOL; PROMETHAZINE; PROPRANOLOL; PROSTAGLANDIN SYNTHASE; RIZATRIPTAN; SUMATRIPTAN; SUMATRIPTAN SUCCINATE; TIZANIDINE; TOPIRAMATE; TRIPTAN DERIVATIVE; VALPROATE SEMISODIUM; VERAPAMIL; ZOLMITRIPTAN;

ALOPECIA; ANOREXIA; ARTICLE; ATAXIA; BLURRED VISION; BRADYCARDIA; CEREBROSPINAL FLUID; CEREBROVASCULAR DISEASE; CHRONIC DAILY HEADACHE; CLUSTER HEADACHE; CONFUSION; CONSTIPATION; COUGHING; DEPRESSION; DIAGNOSTIC TEST; DIARRHEA; DIZZINESS; DRUG HALF LIFE; DRUG SAFETY; EDEMA; EXTRAPYRAMIDAL SYNDROME; FATIGUE; GLAUCOMA; HEART ARRHYTHMIA; HUMAN; HYPERTHERMIA; HYPOTENSION; INFECTION; LIVER FAILURE; METABOLIC ACIDOSIS; MIGRAINE; MUSCULOSKELETAL DISEASE; NAUSEA; NAUSEA AND VOMITING; NEPHROLITHIASIS; NERVE STIMULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; OPHTHALMOSCOPY; PANCREATITIS; PAPILLEDEMA; PARESTHESIA; PHYSICAL EXAMINATION; PRIMARY HEADACHE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHINORRHEA; SEDATION; SEIZURE; SEXUAL BEHAVIOR; SIDE EFFECT; SLEEP; SLEEP DISORDER; SLURRED SPEECH; SNEEZING; STANDING; TENSION HEADACHE; THIRST; THROMBOCYTOPENIA; THUNDERCLAP HEADACHE; TREATMENT PLANNING; TREMOR; TRIGEMINAL AUTONOMIC CEPHALALGIA; VALSALVA MANEUVER; WEAKNESS; WEIGHT GAIN; WEIGHT REDUCTION;

DIAGNOSIS, DIFFERENTIAL; HEADACHE DISORDERS, PRIMARY; HEADACHE DISORDERS, SECONDARY; HUMANS; MIGRAINE DISORDERS; TENSION-TYPE HEADACHE; TRIGEMINAL AUTONOMIC CEPHALALGIAS;

EID: 79951798347     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0031-1271313     Document Type: Article

References (62)

1. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004 24 Suppl 1 9-160
2. Lipton R B., Stewart W F., Simon D. Medical consultation for migraine: results from t (Pubitemid 28155226)
3. Lipton R B., Stewart W F., Diamond S, Diamond M L., Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001 41 7 646-657 (Pubitemid 32777747)
4. Lipton R B., Diamond S, Reed M, Diamond M L., Stewart W F. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 2001 41 7 638-645 (Pubitemid 32777746)
5. Olesen J, Bousser M G., Diener H C. et al, Headache Classification Committee. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006 26 6 742-746
6. Ferrari M D., Goadsby P J., Roon K I., Lipton R B. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 2002 22 8 633-658 (Pubitemid 36609333)
7. Wenzel R G., Tepper S, Korab W E., Freitag F. Serotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA's alert warranted? Ann Pharmacother 2008 42 11 1692-1696
8. Pascual J, Leira R, Linez J M. Combined therapy for migraine prevention? Clinical experience with a beta-blocker plus sodium valproate in 52 resistant migraine patients. Cephalalgia 2003 23 10 961-962 (Pubitemid 37521948)
9. Blumenfeld A M., Schim J D., Chippendale T J. Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine. Headache 2008 48 2 210-220 (Pubitemid 351178286)
10. Mathew N T., Jaffri S F. A double-blind comparison of onabotulinumtoxinA (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study. Headache 2009 49 10 1466-1478
11. Rollnik J D., Wohlfarth K, Dengler R, Bigalke H. Neutralizing botulinum toxin type a antibodies: clinical observations in patients with cervical dystonia. Neurol Clin Neurophysiol 2001 2001 3 2-4
12. Herrmann J, Geth K, Mall V et al. Clinical impact of antibody formation to botulinum toxin A in children. Ann Neurol 2004 55 5 732-735 (Pubitemid 38544335)
13. Shuhendler A J., Lee S, Siu M et al. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials. Pharmacotherapy 2009 29 7 784-791
14. Aurora S K., Dodick D W., Turkel C C. et al, PREEMPT 1 Chronic Migraine Study Group. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 2010 30 7 793-803
15. Dodick D W., Turkel C C., DeGryse R E. et al, PREEMPT Chronic Migraine Study Group. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 2010 50 6 921-936
16. Newman L, Mannix L K., Landy S et al. Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. Headache 2001 41 3 248-256 (Pubitemid 32242609)
17. MacGregor E A., Brandes J L., Silberstein S et al. Safety and tolerability of short-term preventive frovatriptan: a combined analysis. Headache 2009 49 9 1298-1314
18. Rothrock J F. Menstrual migraine. Headache 2009 49 9 1399-1400
19. Garza I, Swanson J W. Prophylaxis of migraine. Neuropsychiatr Dis Treat 2006 2 3 281-291 (Pubitemid 44566705)
20. Goadsby P J., Cittadini E, Burns B, Cohen A S. Trigeminal autonomic cephalalgias: diagnostic and therapeutic developments. Curr Opin Neurol 2008 21 3 323-330 (Pubitemid 351653983)
21. Fischera M, Marziniak M, Gralow I, Evers S. The incidence and prevalence of cluster headache: a meta-analysis of population-based studies. Cephalalgia 2008 28 6 614-618 (Pubitemid 351614944)
22. Ladda J, Straube A, Frderreuther S, Krause P, Eggert T. Quantitative sensory testing in cluster headache: increased sensory thresholds. Cephalalgia 2006 26 9 1043-1050 (Pubitemid 44199395)
23. Bahra A, Gawel M J., Hardebo J E., Millson D, Breen S A., Goadsby P J. Oral zolmitriptan is effective in the acute treatment of cluster headache. Neurology 2000 54 9 1832-1839 (Pubitemid 30428413)
24. Hedlund C, Rapoport A M., Dodick D W., Goadsby P J. Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies. Headache 2009 49 9 1315-1323
25. Hardebo J E., Dahlf C. Sumatriptan nasal spray (20 mg/dose) in the acute treatment of cluster headache. Cephalalgia 1998 18 7 487-489 (Pubitemid 28459466)
26. Ekbom K, The Sumatriptan Cluster Headache Study Group. Treatment of acute cluster headache with sumatriptan. N Engl J Med 1991 325 5 322-326
27. Cohen A S., Burns B, Goadsby P J. High-flow oxygen for treatment of cluster headache: a randomized trial. JAMA 2009 302 22 2451-2457
28. Mathew N T. Dosing and administration of ergotamine tartrate and dihydroergotamine. Headache 1997 37 Suppl 1 S26-S32
29. Matharu M S., Goadsby P J. Trigeminal autonomic cephalalgias: diagnosis and management. In: Silberstein S D. Lipton R B. Dodick D W. eds. Wolff's Headache and Other Head Pain. 8th ed. New York Oxford University Press 2008 379-402
30. Tobin J, Flitman S. Occipital nerve blocks: when and what to inject? Headache 2009 49 10 1521-1533
31. Cohen A S., Matharu M S., Goadsby P J. Electrocardiographic abnormalities in patients with cluster headache on verapamil therapy. Neurology 2007 69 7 668-675 (Pubitemid 47256009)
32. Sostak P, Krause P, Frderreuther S, Reinisch V, Straube A. Botulinum toxin type-A therapy in cluster headache: an open study. J Headache Pain 2007 8 4 236-241 (Pubitemid 350020777)
33. Ailani J, Young W B. The role of nerve blocks and botulinum toxin injections in the management of cluster headaches. Curr Pain Headache Rep 2009 13 2 164-167
34. Jarrar R G., Black D F., Dodick D W., Davis D H. Outcome of trigeminal nerve section in the treatment of chronic cluster headache. Neurology 2003 60 8 1360-1362 (Pubitemid 36460997)
35. Ford R G., Ford K T., Swaid S, Young P, Jennelle R. Gamma knife treatment of refractory cluster headache. Headache 1998 38 1 3-9 (Pubitemid 28125001)
36. Leone M, Franzini A, Broggi G, Bussone G. Hypothalamic stimulation for intractable cluster headache: long-term experience. Neurology 2006 67 1 150-152 (Pubitemid 44305482)
37. Burns B, Watkins L, Goadsby P J. Treatment of intractable chronic cluster headache by occipital nerve stimulation in 14 patients. Neurology 2009 72 4 341-345
38. Schwedt T J., Dodick D W., Trentman T L., Zimmerman R S. Occipital nerve stimulation for chronic cluster headache and hemicrania continua: pain relief and persistence of autonomic features. Cephalalgia 2006 26 8 1025-1027 (Pubitemid 44079730)
39. Rasmussen B K. Epidemiology of headache. Cephalalgia 1995 15 1 45-68
40. Mathew P, Peterlin B. Tension-type headache. In: Jay G W. ed. Clinician's Guide to Chronic Headache and Facial Pain. New York Informa Healthcare 2010 16-26
41. Lyngberg A C., Rasmussen B K., Jrgensen T, Jensen R. Prognosis of migraine and tension-type headache: a population-based follow-up study. Neurology 2005 65 4 580-585 (Pubitemid 41170718)
42. Jensen R, Olesen J. Initiating mechanisms of experimentally induced tension-type headache. Cephalalgia 1996 16 3 175-182 discussion 138-139 (Pubitemid 26163560)
43. Sandrini G, Antonaci F, Pucci E, Bono G, Nappi G. Comparative study with EMG, pressure algometry and manual palpation in tension-type headache and migraine. Cephalalgia 1994 14 6 451-457 discussion 394-395 (Pubitemid 24381761)
44. Jensen R, Fuglsang-Frederiksen A. Quantitative surface EMG of pericranial muscles. Relation to age and sex in a general population. Electroencephalogr Clin Neurophysiol 1994 93 3 175-183 (Pubitemid 24187371)
45. Dahlf C GH, Jacobs L D. Ketoprofen, paracetamol and placebo in the treatment of episodic tension-type headache. Cephalalgia 1996 16 2 117-123 (Pubitemid 26104826)
46. Steiner T J., Lange R, Voelker M. Aspirin in episodic tension-type headache: placebo-controlled dose-ranging comparison with paracetamol. Cephalalgia 2003 23 1 59-66 (Pubitemid 36356807)
47. Prior M J., Cooper K M., May L G., Bowen D L. Efficacy and safety of acetaminophen and naproxen in the treatment of tension-type headache. A randomized, double-blind, placebo-controlled trial. Cephalalgia 2002 22 9 740-748 (Pubitemid 36606054)
48. Kubitzek F, Ziegler G, Gold M S., Liu J M., Ionescu E. Low-dose diclofenac potassium in the treatment of episodic tension-type headache. Eur J Pain 2003 7 2 155-162 (Pubitemid 36330533)
49. Brennum J, Brinck T, Schriver L et al. Sumatriptan has no clinically relevant effect in the treatment of episodic tension-type headache. Eur J Neurol 1996 3 23-28 (Pubitemid 26072918)
50. Cady R K., Gutterman D, Saiers J A., Beach M E. Responsiveness of non-IHS migraine and tension-type headache to sumatriptan. Cephalalgia 1997 17 5 588-590 (Pubitemid 27322019)
51. Bendtsen L, Jensen R. Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache. Cephalalgia 2000 20 6 603-610 (Pubitemid 32269481)
52. Goadsby T, Silberstein S, Dodick D. Chronic Daily Headache for Clinicians. Hamilton BC Decker Inc 2005 57-64
53. Saper J R., Lake A E. III, Cantrell D T., Winner P K., White J R. Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study. Headache 2002 42 6 470-482 (Pubitemid 37011819)
54. Fogelholm R, Murros K. Tizanidine in chronic tension-type headache: a placebo controlled double-blind cross-over study. Headache 1992 32 10 509-513
55. Bendtsen L, Jensen R. Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 2004 62 10 1706-1711 (Pubitemid 38661723)
56. Holroyd K A., Labus J S., O'Donnell F J., Cordingley G E. Treating chronic tension-type headache not responding to amitriptyline hydrochloride with paroxetine hydrochloride: a pilot evaluation. Headache 2003 43 9 999-1004 (Pubitemid 37238656)
57. Padberg M, de Bruijn S F., de Haan R J., Tavy D L. Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial. Cephalalgia 2004 24 8 675-680 (Pubitemid 39061258)
58. Rozen D, Sharma J. Treatment of tension-type headache with botox: a review of the literature. Mt Sinai J Med 2006 73 1 493-498 (Pubitemid 43192236)
59. Harden R N., Cottrill J, Gagnon C M. et al. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study. Headache 2009 49 5 732-743
60. Garza I, Schwedt T J. Diagnosis and management of chronic daily headache. Semin Neurol 2010 30 2 154-166
61. Zidverc-Trajkovic J, Pekmezovic T, Jovanovic Z et al. Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up. Cephalalgia 2007 27 11 1219-1225 (Pubitemid 47631900)
62. Bigal M E., Lipton R B. Excessive acute migraine medication use and migraine progression. Neurology 2008 71 22 1821-1828